Cytek Biosciences, Inc. earnings per share and revenue

CTKB earnings per share for the last quarter are 0.09 USD whereas the estimation was 0.03 USD which accounts for 200.00% surprise. Company revenue for the same period amounts to 58.60 M USD despite the estimated figure of 56.58 M USD. Estimated earnings per share for the next quarter are -0.03 USD, and revenue is expected to reach 43.59 M USD. Also watch annual changes over time to get a bigger picture of CTKB earnings per share and revenue dynamics.